Collaboration, data, and digital innovation are crucial to supporting the future of cell and gene therapy manufacturing. We are delighted to share key highlights from a recent roundtable discussion with CGT thought leaders, including CEO & Co-founder Alexander Seyf, as featured in Discover Pharma’s insightful article.

Key highlights include:
👉 Breaking down data silos
👉 The potential of standardization
👉 Accelerating early digital and AI adoption
👉 Trust as the bedrock of effective data collaboration

At Autolomous, we’re committed to driving digital transformation, streamlining manufacturing processes, and expanding access to life-changing cell and gene therapies.

Read the full article here.